Industry & Policy News

[Immatics] Moderna, Inc. and Immatics N.V. announced a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need.

[Mount Sinai] The National Cancer Institute has awarded the Icahn School of Medicine at Mount Sinai a $3.4 million grant to create a model that identifies the best prostate cancer treatment for people with HIV.

[Verona Pharma plc] Verona Pharma plc announced the US FDA accepted for review the company’s New Drug Application seeking approval of ensifentrine for the maintenance treatment of patients with COPD.

[Nature News] Many publishers, including Elsevier and Springer Nature, have said that authors can use ChatGPT and other large language model (LLM) tools to help them produce their manuscripts, as long as they declare it.

[University of Missouri] Dr. Andrew Kelleher, assistant professor in the Department of Obstetrics, Gynecology and Women’s Health at the University of Missouri School of Medicine has been awarded a five-year, $2.17 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study the ability of cells in a women’s uterine endometrial lining to regenerate in a manner similar to stem cells.

[ScienceInsider] When Svetlana Mojsov heard the spring 2021 announcement, she was startled. The Canada Gairdner International Award, a prestigious biomedical research prize, would be bestowed on three scientists for work underpinning the diabetes and obesity drugs that have exploded in popularity in recent years. “I was really upset,” recalls Mojsov, a chemist at Rockefeller University.